Languita, Estelita .
HRN: 11-23-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2024
CEFUROXIME 500MG (TAB)
04/22/2024
04/29/2024
PO
500mg Tab
BID
UTI, CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes